<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>advanced cancer &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/advanced-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 20 Dec 2025 11:40:19 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>advanced cancer &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Melatonin Boosts Quality of Life in Older Cancer Patients</title>
		<link>https://bioengineer.org/melatonin-boosts-quality-of-life-in-older-cancer-patients/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 20 Dec 2025 11:40:13 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[advanced cancer]]></category>
		<category><![CDATA[Melatonin]]></category>
		<category><![CDATA[older patients]]></category>
		<category><![CDATA[Quality of Life]]></category>
		<category><![CDATA[randomized controlled trial]]></category>
		<guid isPermaLink="false">https://bioengineer.org/melatonin-boosts-quality-of-life-in-older-cancer-patients/</guid>

					<description><![CDATA[Recent research has shed light on the potential benefits of melatonin supplementation for enhancing the quality of life in older patients battling advanced cancer. The study, which has gained significant attention, is a randomized controlled trial led by Ginzac, Bourbouloux, and Rivoirard, along with their esteemed colleagues. As advanced cancer patients often experience debilitating symptoms, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">309831</post-id>	</item>
	</channel>
</rss>
